$BXRX Baudax Bio, Inc. Insider Trading
Get free email notifications about insider trading in Baudax Bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Baudax Bio, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Baudax Bio, Inc. for free.
CIK Number: 0001780097
IRS Number: 474639500
Industry: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
Trading Symbol: BXRX
Company Address: 490 LAPP ROAD MALVERN 19355
Former name: Recro Enterprises, Inc., date of change: 2019-06-18
Baudax Bio, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | BXRX | Baudax Bio, Inc. | Baskies Arnold M | Director | Buy | P | 0.82 | 10,000 | 8,200 | 86,452 | 76.5 K to 86.5 K (+13.08 %) |
May 10 2021 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Buy | P | 0.83 | 6,000 | 4,992 | 356,307 | 350.3 K to 356.3 K (+1.71 %) |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | Baskies Arnold M | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | Baskies Arnold M | Director | Grant | A | 0.00 | 56,452 | 0 | 76,452 | 20 K to 76.5 K (+282.26 %) |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 56,452 | 0 | 119,985 | 63.5 K to 120 K (+88.85 %) |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | Drechsler Andrew T | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | Drechsler Andrew T | Director | Grant | A | 0.00 | 56,452 | 0 | 76,452 | 20 K to 76.5 K (+282.26 %) |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | CHURCHILL WINSTON J | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | CHURCHILL WINSTON J | Director | Grant | A | 0.00 | 56,452 | 0 | 132,185 | 75.7 K to 132.2 K (+74.54 %) |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | Ashton William | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | Ashton William | Director | Grant | A | 0.00 | 56,452 | 0 | 107,185 | 50.7 K to 107.2 K (+111.27 %) |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | ALTOMARI ALFRED | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | ALTOMARI ALFRED | Director | Grant | A | 0.00 | 56,452 | 0 | 117,785 | 61.3 K to 117.8 K (+92.04 %) |
Mar 16 2021 | BXRX | Baudax Bio, Inc. | Casten Richard S | Chief Financial Off ... | Buy | P | 1.41 | 25,000 | 35,180 | 125,000 | 100 K to 125 K (+25.00 %) |